192 related articles for article (PubMed ID: 28369717)
1. Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
Sabra MM; Sherman EJ; Tuttle RM
Cancer; 2017 Aug; 123(15):2955-2964. PubMed ID: 28369717
[TBL] [Abstract][Full Text] [Related]
2. Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time?
Song E; Ahn J; Jeon MJ; Lee SM; Lee JH; Kim TY; Baek JH; Kim WB; Shong YK; Kim WG
Thyroid; 2020 Mar; 30(3):418-424. PubMed ID: 31880976
[No Abstract] [Full Text] [Related]
3. Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
Yeh T; Yeung M; Sherman EJ; Tuttle RM; Sabra MM
Thyroid; 2020 Aug; 30(8):1112-1119. PubMed ID: 32131709
[No Abstract] [Full Text] [Related]
4. Prolongation of tumour volume doubling time (midDT) is associated with improvement in disease-specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapy.
Sabra MM; Sherman E; Tuttle RM
Clin Endocrinol (Oxf); 2019 Apr; 90(4):617-622. PubMed ID: 30706513
[TBL] [Abstract][Full Text] [Related]
5. Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.
Sabra MM; Ghossein R; Tuttle RM
Thyroid; 2016 Apr; 26(4):518-24. PubMed ID: 26872102
[TBL] [Abstract][Full Text] [Related]
6. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M
Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
[TBL] [Abstract][Full Text] [Related]
7. Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
Kim M; Kim WG; Park S; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Jan; 27(1):49-58. PubMed ID: 27750021
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer.
Dackiw AP; Ezzat S; Huang P; Liu W; Asa SL
Endocrinology; 2004 Dec; 145(12):5840-6. PubMed ID: 15319350
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with
Zhang XY; Song HJ; Qiu ZL; Shen CT; Chen XY; Sun ZK; Wei WJ; Zhang GQ; Luo QY
Endocrine; 2018 Oct; 62(1):149-158. PubMed ID: 30022382
[TBL] [Abstract][Full Text] [Related]
10. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
11. [Management and prognostic factors for 119 patients with follicular thyroid carcinoma].
Liu WS; Zhang GF; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):778-82. PubMed ID: 24378102
[TBL] [Abstract][Full Text] [Related]
12. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
13. Pituitary metastasis of follicular thyroid carcinoma.
Chrisoulidou A; Pazaitou-Panayiotou K; Flaris N; Drimonitis A; Giavroglou I; Ginikopoulou E; Vainas I
Horm Res; 2004; 61(4):190-2. PubMed ID: 14739527
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
Wassermann J; Bernier MO; Spano JP; Lepoutre-Lussey C; Buffet C; Simon JM; Ménégaux F; Tissier F; Leban M; Leenhardt L
Oncologist; 2016 Jan; 21(1):50-8. PubMed ID: 26675742
[TBL] [Abstract][Full Text] [Related]
15. Remarkable Response of Pulmonary Metastases Rather Than Remnant Thyroid in 131I Therapy of Follicular Thyroid Cancer.
Tian T; Chen Y; Xiang Y; Liu L; Liu B
Clin Nucl Med; 2019 Apr; 44(4):327-329. PubMed ID: 30688748
[TBL] [Abstract][Full Text] [Related]
16. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
18. Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
Brose MS; Smit J; Lin CC; Pitoia F; Fellous M; DeSanctis Y; Schlumberger M; Tori M; Sugitani I
Endocr Relat Cancer; 2017 May; 24(5):237-242. PubMed ID: 28270435
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
20. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
